Grusby
Alan Grusby, Champaign, IL US
Patent application number | Description | Published |
---|---|---|
20150056324 | ARCHER DANIELS MIDLAND COMPANY - Processes for producing animal feeds from biomasses are disclosed. Uses of the processed biomasses and, optionally industrial co-products, as animal feeds are also disclosed. | 02-26-2015 |
Alvin Grusby, Newton, MA US
Patent application number | Description | Published |
---|---|---|
20100078804 | Apparatus with Side Mounted Microchip - In accordance with one embodiment of the invention, a packaged microchip has 1) a base with a mounting surface having a given electrical interconnector, and 2) a microchip with a plurality of side surfaces, a top surface, a bottom surface, and a given electrical pad on at least one of the top and bottom surfaces. The packaged microchip also has 3) a given solder ball secured to one of the top and bottom surfaces of the microchip. The given solder ball also is connected to the given electrical interconnector to electrically connect the given electrical pad and the given electrical interconnector. At least one side surface of the microchip is generally parallel with the mounting surface of the base. | 04-01-2010 |
Michael Grusby, Newton, MA US
Patent application number | Description | Published |
---|---|---|
20100223685 | IL-21 RECEPTOR KNOCKOUT ANIMAL AND METHODS OF USE THEREOF - A transgenic non-human mammal with a disruption in its IL-21 receptor gene is provided, along with methods of using the transgenic non-human mammal. | 09-02-2010 |
Michael J. Grusby, Newton, MA US
Patent application number | Description | Published |
---|---|---|
20090197803 | METHODS AND COMPOSITIONS FOR MODULATING T HELPER (Th) CELL DEVELOPMENT AND FUNCTION - Methods and compositions for modulating T helper (Th) cell development and function using modulators of IL-21, e.g., human IL-21, activity or level. | 08-06-2009 |
20110142833 | METHODS FOR TREATING AND PREVENTING FIBROSIS - The present invention provides methods of screening for compositions useful for treating, ameliorating, or preventing fibrosis and/or fibrosis-associated conditions by measuring changes in the level(s) of IL-21 and/or IL-21 receptor (IL-21R) (e.g., the level of expression of IL-21 and/or IL-21R protein and/or mRNA, the level of activity of IL-21 and/or IL-21R, the level of interaction of IL-21 with IL-21R). The invention further provides antagonists of IL-21 or IL-21R for the treatment of fibrosis and/or fibrosis-associated conditions. Further provided herein are methods of diagnosing, prognosing, and monitoring the progress (e.g., the course of treatment) of fibrosis and/or fibrosis-associated conditions by measuring the level of IL-21 and/or IL-21R (i.e., the level of activity of IL-21 and/or IL-21R, the level of expression of IL-21 and/or IL-21R (e.g., the level of IL-21 and/or IL-21R gene products), and/or the level of interaction of IL-21 with IL-21R). | 06-16-2011 |